Donald R. Allan

440 total citations
15 papers, 366 citations indexed

About

Donald R. Allan is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Donald R. Allan has authored 15 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Donald R. Allan's work include Renin-Angiotensin System Studies (4 papers), Hormonal Regulation and Hypertension (4 papers) and Receptor Mechanisms and Signaling (3 papers). Donald R. Allan is often cited by papers focused on Renin-Angiotensin System Studies (4 papers), Hormonal Regulation and Hypertension (4 papers) and Receptor Mechanisms and Signaling (3 papers). Donald R. Allan collaborates with scholars based in Canada, United States and United Kingdom. Donald R. Allan's co-authors include Naomi D.L. Fisher, Imre Kifor, S. Brian Penner, D D Smyth, John McKnight, Cynthia L. Gaboury, Norman K. Hollenberg, Caroline Coletti, N. K. Hollenberg and Gordon H. Williams and has published in prestigious journals such as Kidney International, Hypertension and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Donald R. Allan

15 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Donald R. Allan Canada	9	181	124	109	50	47	15	366
Keiichi Sugimura Japan	8	244 1.3×	170 1.4×	122 1.1×	38 0.8×	16 0.3×	16	365
Midori Okamura Japan	11	84 0.5×	52 0.4×	114 1.0×	32 0.6×	19 0.4×	13	336
Heikki Mäkynen Finland	11	200 1.1×	62 0.5×	92 0.8×	21 0.4×	41 0.9×	27	361
M. Shintani Japan	9	139 0.8×	166 1.3×	75 0.7×	46 0.9×	33 0.7×	12	454
Bong H. Roh United States	10	55 0.3×	72 0.6×	150 1.4×	49 1.0×	19 0.4×	12	548
Valeria Burghi Argentina	11	192 1.1×	116 0.9×	129 1.2×	37 0.7×	12 0.3×	14	350
A Blackwood United Kingdom	9	233 1.3×	155 1.3×	37 0.3×	33 0.7×	23 0.5×	10	337
Maria Beatriz Sayeg Freire Brazil	8	112 0.6×	140 1.1×	94 0.9×	30 0.6×	9 0.2×	11	320
Hisakazu Nakajima Japan	11	76 0.4×	77 0.6×	112 1.0×	61 1.2×	23 0.5×	43	389
Che Ping Cheng United States	12	254 1.4×	89 0.7×	159 1.5×	23 0.5×	14 0.3×	28	419

Countries citing papers authored by Donald R. Allan

Since Specialization

Citations

This map shows the geographic impact of Donald R. Allan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald R. Allan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald R. Allan more than expected).

Fields of papers citing papers by Donald R. Allan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald R. Allan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald R. Allan. The network helps show where Donald R. Allan may publish in the future.

Co-authorship network of co-authors of Donald R. Allan

This figure shows the co-authorship network connecting the top 25 collaborators of Donald R. Allan. A scholar is included among the top collaborators of Donald R. Allan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald R. Allan. Donald R. Allan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Lacourcière, Yves, Jacques Lévesque, Stephanie R. Wilson, et al.. (2002). Impact of Levovist ultrasonographic contrast agent on the diagnosis and management of hypertensive patients with suspected renal artery stenosis: a Canadian multicentre pilot study.. PubMed. 53(4). 219–27. 3 indexed citations

Lévesque, Jacques, Yves Lacourcière, Stephanie R. Wilson, et al.. (2002). Economic impact of an ultrasonographic contrast agent on the diagnosis and initial management of patients with suspected renal artery stenosis.. PubMed. 53(4). 228–36. 2 indexed citations

Pimentel, Mark, James B. Johnston, Donald R. Allan, Howard Greenberg, & Çharles N. Bernstein. (1997). Primary Adrenal Lymphoma Associated with Adrenal Insufficiency: A Distinct Clinical Entity. Leukemia & lymphoma. 24(3-4). 363–367. 40 indexed citations

Allan, Donald R., K. Y. Hui, Caroline Coletti, & N. K. Hollenberg. (1997). Renin vs. Angiotensin-Converting Enzyme Inhibition in the Rat: Consequences for Plasma and Renal Tissue Angiotensin. Journal of Pharmacology and Experimental Therapeutics. 283(2). 661–665. 10 indexed citations

Price, Deborah A., et al.. (1997). Autonomy of the renin system in type II diabetes mellitus: Dietary sodium and renal hemodynamic responses to ACE inhibition. Kidney International. 52(3). 771–777. 58 indexed citations

Allan, Donald R., S. Brian Penner, & Donald D. Smyth. (1996). Antagonism by idazoxan at low dose but not high dose, of the natriuretic action of moxonidine. British Journal of Pharmacology. 117(1). 29–34. 3 indexed citations

Fisher, Naomi D.L., Donald R. Allan, Cynthia L. Gaboury, & Norman K. Hollenberg. (1995). Intrarenal Angiotensin II Formation in Humans. Hypertension. 25(5). 935–939. 14 indexed citations

Fisher, Naomi D.L., Donald R. Allan, Imre Kifor, et al.. (1994). Responses to converting enzyme and renin inhibition. Role of angiotensin II in humans.. Hypertension. 23(1). 44–51. 68 indexed citations

Allan, Donald R., John McKnight, Imre Kifor, Caroline Coletti, & N. K. Hollenberg. (1994). Converting enzyme inhibition and renal tissue angiotensin II in the rat.. Hypertension. 24(4). 516–522. 46 indexed citations

10.

Vigushin, David M., J Gough, Donald R. Allan, et al.. (1994). Familial nephropathic systemic amyloidosis caused by apolipoprotein Al variant Arg26. QJM. 87(3). 149–54. 47 indexed citations

11.

Allan, Donald R., S. Brian Penner, & D D Smyth. (1993). Renal imidazoline preferring sites and solute excretion in the rat. British Journal of Pharmacology. 108(4). 870–875. 52 indexed citations

12.

Roulston, J E & Donald R. Allan. (1987). Studies with an automated kinetic assay for plasma angiotensin-converting enzyme activity and its potentiation by zinc ion. Clinica Chimica Acta. 168(2). 187–198. 6 indexed citations

13.

Roulston, J E, Donald R. Allan, & Sean Gow. (1986). Elevation of Plasma Angiotensin-Converting Enzyme (ACE) in Patients with Hyperthyroidism. Clinical Science. 70(s13). 40P–40P. 1 indexed citations

14.

Allan, Donald R., et al.. (1983). Chronic granulomatous disease with associated oral lesions. BDJ. 154(4). 110–112. 3 indexed citations

15.

Craig, G.T., et al.. (1979). Disseminated histoplasmosis presenting with oral lesions - report of a case. British Journal of Oral Surgery. 16(3). 234–240. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact